Echeverría MCA, Hurtado EG, Pardo MRV

Language: Spanish
References: 26
Page: 53-58
PDF size: 52.37 Kb.

ABSTRACT

Introduction: It is important to study young patients as it has been an increase in the lower genital tract pathology. Objective: The colposcopic findings of the adolescent patients at the Hospital of Gynecology and Obstetrics, Maternal and Child Institute of the State of Mexico. Material and methods: All adolescent patients were sent for colposcopy with a diagnosis of abnormal cytology or sexually transmitted disease. Colposcopy was performed, the diagnosis of premalignant lesions were confirmed by biopsy histopathology. Results: Of a total of 110 patients, mean age was 16.2 years and the onset of sexual activity was on average at 16.4 years, with a percentage of 58.18% with a sexual partner and a 19.09% more than three sexual partners. Within the colposcopic findings and in benign lesions were observed in 11 patients with cervical polyps (10%), seven with molluscum contagiosum (6.36%), 19 with glandular eversion (17.27%) and 24 patients with vulvar and perineal condilomatosis (21.81%). In premalignant lesions were observed 56 patients with minor (50.90%) and 18 patients with major changes (16.36%). Treatment options we show satisfactory response rate in this type of injury at this age. Conclusions: We propose a percentage up because the resolution of benign and premalignant lesions of the cervix even if we lack clear that studies with sufficient scientific evidence to support this fact.

REFERENCES

1. Rodríguez RM. Mesa redonda: Adolescencia. Necesidad de creación de unidades de adolescencia, An Pediatr, 2003; 58: 104-106.

2. Dulanto. El adolescente. Asociación Mexicana de Pediatría, A.C. Décima Edición, Editorial Mc Graw-Hill Interamericana, México, 2002: 97-105.

3. Moscicki AB. Impact of HPV infection in adolescent populations, Journal of Adolescent Health, 2005; 37: S3-S9.

4. Brown DR, Shew ML, Qadadri B. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women, J Infect Dis, 2005; 191: 182-92.

5. Zimet GD. Improving adolescent health: Focus on HPV vaccine acceptance, Journal of Adolescent Health, 2005; 37: S17-S23

6. Martinón-Torres F, Bernaola-Iturbe E, Jiménez-Sánchez F, Baca Cots M, De Juan Martín F, Díez Domingo J et al. Vacuna frente al virus del papiloma humano: un nuevo reto para el pediatra, An Pediatr (Barc), 2006; 65 (5): 461-69.

7. Olshen E, Woods ER, Austin SB. Parental acceptance of the human papillomavirus vaccine, Journal Adolescent Health, 2005; 37: 248-51.

8. Saslow D, Runowicz CD, Solomon D. American Cancer Society guide line for the early detection of cervical neoplasia and cancer, Cancer J Clin, 2002; 52: 342.

9. Puig Tintoré LM. Neoplasia intraepitelial del cérvix: diagnóstico, tratamiento y seguimiento. En: Cabero L. Tratado de ginecología, obstetricia y medicina de la reproducción, Buenos Aires: Editorial Panamericana, 1a edición, 2006.

10. Franceschi S, Herrero R, Clifford GM et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide, Int J Cancer, 2006; 119: 2677.

11. Moscicki AB, Ma Y, Holland C et al. Cervicalectopy in adolescent girls with and without Human immunodeficiency virus infection, J Infect Dis, 2001; 183: 865.

12. Winer RL, Lee SK, Hughes JP et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students, Am J Epidemiol, 2003; 157: 218.

13. Brown DR, Shew ML, Qadadri B et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women, J Infect Dis, 2005; 191:182.

14. Moscicki AB, Hills N, Shiboski S et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females, JAMA 2001; 285: 2995.

15. Winer RL, Hughes JP, Feng Q et al. Condom use and the risk of genital human papilloma virus infection in young women, N Engl J Med, 2006; 354: 2645.

16. Moscicki AB, Singer A. The cervical epithelium during puberty and adolescence. In: Jordan JA, Singer A, editors, The cervix 2nd edition, Malden, (MA): Blackwell, 2006: 81.

17. Doorbar J, Foo C, Coleman N et al. Characterization of events during the late stages of HPV 16 infection in vivo us using high-affinity synthetic Fabs to E4, Virology, 1997; 238: 40.

18. Moscicki AB, Burt VG, Kanowitz S et al .The significance of squamous metaplasia in the development of low grades quamous intraepithelial lesions in young women, Cancer, 1999; 85: 1139.

19. Mount SL, Papillo JL. A study of 10 296 pediatric and adolescent Papanicolaous mear diagnoses in Northern New England, Pediatrics, 1999; 103: 539.

20. Claudio Sterm. El embarazo en la adolescente como problema público, Salud Pública de México, 2004; 39 (2): 137-143.

21. Issler J R. Embarazo en la adolescencia. Revista de Postgrado de la Cátedra Vía Medicina, 2004; 107: 22-28.

22. Donoso SE. Mortalidad perinatal en la adolescencia, Rev Panamericana de Salud Pública, 2004; 14: 3-9.

23. Norma Oficial Mexicana NOM-014-SSA2-1994. Para la prevención, tratamiento y control de cáncer del cuello de útero y de la mama en la atención primaria.

24. Agramunt D, Solomon D, Davey D, Kurman R, Moiarty A, O’Connor D et al. The 2001 Bethesda system terminology for reporting results of cervical cytology, JAMA, 2002; 287: 2114-9.

25. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis, BMJ, 2008; (337): 1275-84.

26. Moore K, Cofer A, Elliot L, Lanneau G, Walker J, Gold MA. Adolescent cervical displasia: histologic evaluation, treatment, and outcomes, Am J Obstet Gynecol, 2007; 197 (2): 141-6.